纳米颗粒的口服吸收及其临床翻译潜力
Kyoung Sub Kim1, Kun Na2, You Han Bae3
1Department of Biotechnology, The Catholic University of Korea, 43 Jibong-ro, Wonmi-gu, Bucheon-si, Gyeonggi-do 14662, Republic of Korea.
概括
开发口服纳米颗粒 (NP) 面临着有效提供活性药物成分 (API) 的挑战. 本综述强调了从临床前模型改进口服NP转化潜力的关键参数,从临床前模型改进到人体应用.
科学领域:
- 制药科学 制药科学
- 纳米技术纳米技术
- 药物运输 药物运输 药物运输
背景情况:
- 口服药物管理是首选的,但对于难以溶解,大或不稳定的活性药物成分 (API) 来说具有挑战性.
- 纳米粒子 (NP) 已被开发用于通过各种吸收途径提高口服生物可用性.
- 临床前发现往往无法转化为人类的疗效,这是由于物种差异和生理变异.
研究的目的:
- 审查关键参数,以提高口服纳米粒子 (NP) 药物递送系统的翻译潜力.
- 确定影响口服NP在临床前模型与人类应用中的疗效的因素.
主要方法:
- 对纳米粒子 (NP) 口服输送策略的文献综述.
- 分析影响口服生物可用性和从动物模型转化到人类的因素.
- 讨论设计口服生物可用NP的选择标准.
主要成果:
- 在NP中API的口服生物可用性是高度可变的,受物种,生理学,年龄和疾病状态的影响.
- 目前的NP方法在人类中达到足够的治疗度方面取得了有限的成功.
- 临床前数据经常无法准确预测口服NP输送对人类的结果.
结论:
- 仔细选择设计参数对于成功的口服纳米粒子开发至关重要.
- 解决翻译性挑战需要对特定物种和特定患者的因素有更深入的了解.
- 未来的研究应该专注于优化NP设计,以便在人类中可靠地进行口服.
相关概念视频
Factors Affecting Dissolution: Particle Size and Effective Surface Area
898
Dissolution kinetics, an essential aspect of oral drug delivery, is significantly influenced by the drug's particle size. According to the Noyes-Whitney dissolution model, the dissolution rate correlates directly with the drug's surface area. The larger the surface area, the higher the drug's solubility in water, leading to a faster drug dissolution rate. Reducing particle size increases the effective surface area, enhancing the dissolution process. Micronization and nanosizing are...
898
Non-Oral Extravascular Drug Absorption Routes
240
Non-oral extravascular routes, which encompass sublingual, buccal, topical, intramuscular, and inhalation methods, primarily utilize passive diffusion to transport drugs into the systemic circulation. The absorption rates and effectiveness of these routes depend on the drug's physicochemical properties, as well as the patient's anatomical and pathophysiological state.
Lipophilic drugs that are stable at salivary pH (6) and exhibit minimal binding to the oral mucosa are absorbed more...
Lipophilic drugs that are stable at salivary pH (6) and exhibit minimal binding to the oral mucosa are absorbed more...
240
Factors Influencing Drug Absorption: Presystemic Elimination
267
The pharmacokinetic journey of oral drugs begins with a crucial first pass through the hepatic portal system, called the first-pass effect. This first pass significantly impacts bioavailability — the proportion of a drug that enters systemic circulation and is available for therapeutic action. The primary route sees the drug absorbed by intestinal membranes and then shunted to the liver via the hepatic portal vein. Here, pre-systemic elimination occurs as drugs face metabolism or biliary...
267
Drug Absorption: Overview
684
The process of drug absorption signifies the transition of a drug from its site of administration into the plasma. This process is influenced by various factors, including the route of administration, the anatomy of the absorption site, the mechanism of absorption, gut motility, and the drug's physicochemical properties.
When drugs are injected intravenously, they directly enter the systemic circulation. Alternatively, orally administered drugs navigate through the gastrointestinal (GI)...
When drugs are injected intravenously, they directly enter the systemic circulation. Alternatively, orally administered drugs navigate through the gastrointestinal (GI)...
684
Biopharmaceutics and Pharmacokinetics: Overview
2.1K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
2.1K
Factors Influencing Drug Absorption: Drug Dissolution
590
The pharmacokinetic journey of drugs from solid oral dosage forms into systemic circulation is multifaceted. It begins with disintegration, a prerequisite ensuring a solid dosage form's subdivision into minute particles. Dissolution occurs next as these granulated entities solubilize in gastrointestinal fluids. This solubilization is crucial for the succeeding stage, permeation, which describes the traversal of the drug across the intestinal membrane and its subsequent entry into the blood...
590


